Discontinuation report PMS-DILTIAZEM CD
Report ID | 25702 |
Drug Identification Number | 02355787 |
Brand name | PMS-DILTIAZEM CD |
Common or Proper name | DILTIAZEM |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE (CONTROLLED-DELIVERY) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C08DB |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | 2017-10-15 |
Actual discontinuation date | 2017-10-15 |
Remaining supply date | 2017-10-10 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | NO SUPPLY |
Company comments | IN DEACTIVATION PROCESS |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2017-10-16 | English | Compare |
v2 | 2017-10-12 | French | Compare |
v1 | 2017-10-12 | English | Compare |
Showing 1 to 3 of 3